Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
Nephros, Inc. (NEPH)
NASDAQ:AMEX Investor Relations:
nephros.com/investor-relations
Company Research
Source: GlobeNewswire
SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced the pricing of a firm commitment underwritten offering of 937,500 shares of common stock at a price to the public of $8.00 per share for aggregate gross proceeds of approximately $7,500,000, before underwriting discounts and offering expenses. The offering is expected to close on or about February 4, 2020, subject to the satisfaction of customary closing conditions. Craig-Hallum Capital Group is acting as sole managing underwriter for the offering. Maxim Group LLC and The Benchmark Company, LLC are each acting as financial advisors to Nephros. Net proceeds of the offering, after underwriting discounts but before offering expenses, are expected to be approximately
Show less
Read more
Impact Snapshot
Event Time:
NEPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEPH alerts
High impacting Nephros, Inc. news events
Weekly update
A roundup of the hottest topics
NEPH
News
- Nephros, Inc. (NASDAQ: NEPH) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.MarketBeat
- Nephros Inc (NEPH) Q3 2024 Earnings Call Highlights: First Profitable Quarter and Strategic ... [Yahoo! Finance]Yahoo! Finance
- Nephros Announces Financial Results for Quarter Ended September 30, 2024 [Yahoo! Finance]Yahoo! Finance
- Nephros Announces Financial Results for Quarter Ended September 30, 2024GlobeNewswire
- What To Expect From Nephros Inc (NEPH) Q3 2024 Earnings [Yahoo! Finance]Yahoo! Finance
NEPH
Sec Filings
- 11/14/24 - Form 10-Q
- 11/13/24 - Form 8-K
- 8/26/24 - Form 8-K
- NEPH's page on the SEC website